Drug Delivery: Surveying the global competitive landscape is a new (March 2013) richly-detailed report which examines, in depth, 106 leading and emerging specialist drug delivery companies. The report covers all major technology areas including controlled-release, nucleic acid, nano-enabled and targeted delivery.
Dallas, TX -- (SBWIRE) -- 03/15/2013 -- The importance of drug-delivery technology grows ever more apparent and commercial and pharma industry interest continues to build. The new biologic products which are coming to market are widening the demand for novel delivery targeted mechanisms. Controlled-release technologies continue to play a crucial role in a product’s life-cycle and the pharma industry is able to extend patent protection and preserve revenues.
The emerging biosimilars market offers great potential for developers of targeted delivery as a range of high-value brands such as Roche’s Herceptin and Avastin will be subject to patent challenges in the coming years. With many biosimilars planned or already in development around the world, the need for novel delivery mechanisms will increase.
This report (http://www.rnrmarketresearch.com/drug-delivery-surveying-the-global-competitive-landscape-market-report.html) provides you with key data for each company.
Company Overview & Technology Focus
Key Agreements & Alliances
Financial Data (where available)
The ability to readily assess the companies involved, compare areas of research interest, profile products being developed, identify strategic collaborations and evaluate performance/funding is key to understanding this market. In 716 information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape (published March 2013) evaluates companies large and small from multinationals to specialist development and technology organisations.
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=84925.
Companies covered in this report include 3M, Access Pharmaceuticals Inc, Acrux Ltd, Acura Pharmaceuticals, Agile Therapeutics, Alkermes Inc, Apricus Biosciences Inc, Aptalis Pharma, Aptar Group, Aradigm Corporation, Atlantic Pharmaceuticals, Baxter International Inc, Bind Biosciences, Biodelivery Sciences International, Bioject Medical Technologies Inc , Bio-Path Holdings, Biosante Pharmaceuticals Inc, Calando Pharmaceuticals, Camurus AB, Carefusion, Celator Pharmaceuticals Inc, Cell Therapeutics Inc, Cephalon, Cipher Pharmaceuticals, Columbia Laboratories Inc, Consort Medical PLC, Cornerstone Therapeutics, Cytimmune Sciences, Debiopharm SA and more. Explore company profile and SWOT analysis reports @ http://www.rnrcompanyprofiles.com/
Complete Table of Contents and more @ http://www.rnrmarketresearch.com/drug-delivery-surveying-the-global-competitive-landscape-market-report.html.
Contact firstname.lastname@example.org for further information. Explore more reports on the Pharmaceuticals industry @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)